Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MA Navarro Davila"'
Autor:
G Calzado Gómez, MA Navarro Davila, S Perez Reyes, C Romero Delgado, S Otazo Perez, Y Gonzalez Perez, M Bullejos Molina, GJ Nazco Casariego
Publikováno v:
Late breaking abstracts.
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Alterations in the lipid profile and increased cardiovascular risk (CV) have been described in those patients treated with JAK kinase inhibitors, such as baricitinb and tofacitinib. Aim and objectives To determine the CV ris